Evidence map›Paper›PMID 36448694›Full record

ArticleNano letters2022

Single Low-Dose Nanovaccine for Long-Term Protection against Anthrax Toxins.

Maya Holay, Nishta Krishnan, Jiarong Zhou, Yaou Duan, Zhongyuan Guo, Weiwei Gao, Ronnie H Fang, Liangfang Zhang

Open access · greenAbstract read
In one paragraph

Article in Nano letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Maya HolayDepartment of NanoEngineering, Chemical Engineering Program, and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, United States.
Nishta KrishnanDepartment of NanoEngineering, Chemical Engineering Program, and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, United States.
Jiarong ZhouDepartment of NanoEngineering, Chemical Engineering Program, and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, United States.
Yaou DuanDepartment of NanoEngineering, Chemical Engineering Program, and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, United States.
Zhongyuan GuoDepartment of NanoEngineering, Chemical Engineering Program, and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, United States.
Weiwei GaoDepartment of NanoEngineering, Chemical Engineering Program, and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, United States.ORCID 0000-0001-5196-4887
Ronnie H FangDepartment of NanoEngineering, Chemical Engineering Program, and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, United States.ORCID 0000-0001-6373-3189
Liangfang ZhangDepartment of NanoEngineering, Chemical Engineering Program, and Moores Cancer Center, University of California, San Diego, La Jolla, California 92093, United States.ORCID 0000-0003-0637-0654
University of California San Diego · US

Funding

Motorized delivery of bacterial antigens to mucosal barriers to enhance immunity against infectionR21AI159492 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FANG, RONNIE H · 2022 to 2023
$435k
NIAID NIH HHS R21 AI159492
6 · The paper itself

Abstract

Anthrax infections caused by

Indexed as

AnthraxAnthrax VaccinesBacterial ToxinsAnimalsAntigens, BacterialBacillus anthracisHumansMiceNanotechnologyanthrax toxinAnthrax VaccinesAntigens, BacterialBacterial Toxinsanthraxantivirulence vaccinebiomimetic nanoparticlecell membrane coatingnanotoxoid

Identifiers

PMID36448694
PMCPMC9970955
OpenAlexW4310461874

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.